Pediatric Drugs

Papers
(The TQCC of Pediatric Drugs is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus52
The Role of Probiotics in the Prevention and Treatment of Atopic Dermatitis in Children: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials46
Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature39
Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy38
Postoperative Nausea and Vomiting in Pediatric Patients33
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-233
Postoperative Pain Management in Pediatric Spinal Fusion Surgery for Idiopathic Scoliosis30
Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus27
Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient25
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria24
Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children23
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review21
Immunotherapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: Advances and Ongoing Challenges21
Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects20
Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents20
Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial20
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study20
The Use of Linaclotide in Children with Functional Constipation or Irritable Bowel Syndrome: A Retrospective Chart Review19
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance18
An Update on CFTR Modulators as New Therapies for Cystic Fibrosis18
Phentermine/Topiramate: Pediatric First Approval18
Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting17
Viloxazine: Pediatric First Approval16
Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial16
Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses16
Adherence to Medication During Transition to Adult Services15
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients15
Pediatric Pharmacology of Desmopressin in Children with Enuresis: A Comprehensive Review15
Ranibizumab: A Review in Retinopathy of Prematurity14
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years14
Lidocaine Infusions for Pain Management in Pediatrics14
Sodium Thiosulfate: Pediatric First Approval13
Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis13
Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands13
External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study12
Managing Patient Pressure to Prescribe Antibiotics in the Clinic12
Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses12
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis12
Metamizole Use in Children: Analysis of Drug Utilisation and Adverse Drug Reactions at a German University Hospital between 2015 and 202011
Pain Management in Children: NSAID Use in the Perioperative and Emergency Department Settings11
Targeted Therapy for Pediatric Psoriasis11
Impact of Antiseizure Medications on Appetite and Weight in Children11
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations11
A Mixed-Methods Analysis of Medication Safety Incidents Reported in Neonatal and Children’s Intensive Care10
An Update of Pharmacological Management in Children with Functional Constipation10
Characteristics of Reported Pediatric Medication Errors in Northern Ireland and Use in Quality Improvement9
Pharmacokinetics of Ceftazidime in Children and Adolescents with Obesity9
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis9
Teriflunomide: Pediatric First Approval9
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study9
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clin9
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia9
Lonapegsomatropin: Pediatric First Approval8
Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis8
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years8
Cardiovascular Drug Therapy during Interstage After Hybrid Approach: A Single-Center Experience in 51 Newborns with Hypoplastic Left Heart8
Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?8
Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary7
Practical Challenges—Use of Paracetamol in Children and Youth Who are Overweight or Obese: A Narrative Review7
Haloperidol and Quetiapine for the Treatment of ICU-Associated Delirium in a Tertiary Pediatric ICU: A Propensity Score-Matched Cohort Study7
Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review7
Eosinophilic Esophagitis: Update on Diagnosis and Treatment in Pediatric Patients7
Effect of Mirtazapine on Nausea in Children with Functional Nausea and Functional Dyspepsia Postprandial Distress Syndrome7
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study7
Immunosuppression Regimens for Intestinal Transplantation in Children7
Prucalopride for Treatment of Upper Gastrointestinal Symptoms in Children7
Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children7
Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects7
0.02422308921814